Developing New Drugs to Treat Breast Cancer

VIDEO | 5:00

Researchers are taking a collaborative approach to developing new medications for breast cancer, according to Larry Norton, Deputy Physician-in-Chief for Breast Cancer Programs at Memorial Sloan Kettering Cancer Center. In one study, called I-SPY-2, scientists are using information from breast tissue imaging and molecular studies to identify genetic risk factors that may predict a woman’s response to therapy, which could accelerate the development of more-effective drugs.